Nyxoah SA (NYXH)
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Specialties
Nyxoah S.A.
NASDAQ:NYXHHealthcare · Medical - Specialties
-1.85%$0.8715
AH$0.8715+0.00%vs close
Mkt Cap$87.21M
Float75.94M
O/S100.07M
Vol
$ Vol
RVOL
Inst Own22.6%
SI0.3%
Earnings
Dilution
Financials Summary
Revenue$11.19M
Net Income-$100.64M
Total Assets$132.31M
Free Cash Flow-$76.31M
Debt & Equity
Debt 46%
Equity 54%
Total Debt$46.99M
Total Equity$54.87M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in NYXH's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$132.31M
Liabilities$77.47M
Accounts Receivable$8.63M
Accounts Payable$15.33M
Inventory$5.2M
PP&E (Net)$5.97M
Goodwill$0
Intangible Assets$55.96M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Revenue | $11.19M | $5.05M | $4.86M | $3.45M | $952K | $77K | $0 | $0 | $0 |
| YoY Growth | 121.6% | 4.0% | 41.0% | 262.0% | 1134.8% | - | - | - | - |
| Cost of Revenue | $4.13M | $1.73M | $1.85M | $1.28M | $339K | $34K | $543K | $106K | $100K |
| Gross Profit | $7.07M | $3.32M | $3.01M | $2.16M | $613K | $44K | -$543K | -$106K | -$100K |
| Gross Margin | 63.1% | 65.7% | 61.9% | 62.7% | 64.4% | 56.5% | - | - | - |
| Research and Development | $47.84M | $38.35M | $30.9M | $17.72M | $6.65M | $3.25M | $1.83M | $1.53M | $1.71M |
| Selling, General, and Administrative | $51.88M | $31.8M | $23.06M | $21.06M | $12.42M | $12.67M | $4.97M | $8.37M | $4.6M |
| Other | $8K | -$1.13M | -$566K | -$316K | $10.87M | -$3.34M | $2.17M | $0 | $3.53M |
| Total Operating Expenses | $99.73M | $69.02M | $53.4M | $38.47M | $29.93M | $12.58M | $8.97M | $9.9M | $9.84M |
| Operating Income (EBIT) | -$92.66M | -$65.7M | -$50.39M | -$36.31M | -$29.32M | -$12.54M | -$9.52M | -$9.44M | -$11.33M |
| Operating Margin | -827.8% | -1300.8% | -1037.3% | -1053.8% | -3080.0% | -16266.7% | - | - | - |
| Interest Expense | $1.89M | $2.13M | $1.35M | $265K | $431K | $221K | $784K | $32K | $41K |
| Interest Income | $2.05M | $2.8M | $2.87M | $416K | $1K | $3K | $10K | $1K | $2K |
| Other Income (Expense) | -$6.85M | $2.66M | $497K | $2.73M | $1.79M | -$1.04M | -$997K | -$657K | -$213K |
| Income Before Tax (EBT) | -$99.52M | -$63.05M | -$49.89M | -$33.58M | -$27.53M | -$13.58M | -$10.51M | -$10.1M | -$11.55M |
| Income Tax Expense | $1.13M | $3.13M | -$1.61M | $1.31M | $3.33M | $104K | $88K | $46K | $41K |
| Net Income | -$100.64M | -$66.18M | -$48.28M | -$34.88M | -$30.86M | -$13.68M | -$9.44M | -$10.14M | -$11.59M |
| Net Income Margin | -899.1% | -1310.2% | -993.8% | -1012.5% | -3241.7% | -17746.4% | - | - | - |
| Supplementary Data | |||||||||
| EPS | -2.36 | -1.81 | -1.55 | -1.21 | -1.16 | -0.68 | -0.39 | -0.43 | -0.50 |
| Diluted EPS | -2.36 | -1.81 | -1.55 | -1.21 | -1.16 | -0.68 | -0.39 | -0.43 | -0.50 |
| Weighted Average OS | 38.11M | 32.74M | 27.97M | 25.82M | 23.79M | 18.10M | 21.42M | 20.89M | 20.89M |
| EBITDA | -$92.62M | -$57.88M | -$47.01M | -$31.16M | -$25.24M | -$11.85M | -$9.25M | -$9.48M | -$9.67M |
| EBITDA Margin | -827.4% | -1146.0% | -967.8% | -904.2% | -2651.5% | -15368.1% | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Assets | |||||||||
| Current Assets | |||||||||
| Cash and Cash Equivalents | $33.5M | $38.19M | $24.14M | $19.98M | $151.39M | $126.17M | $7.34M | $18.77M | $11.29M |
| Short-Term Investments | $20.1M | $57.39M | $40.37M | $85.99M | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $53.61M | $95.58M | $64.52M | $105.97M | $151.39M | $126.17M | $7.34M | $18.77M | $11.29M |
| Accounts Receivable | $8.63M | $6.88M | $6.29M | $2.49M | $2.81M | $2.25M | $2.64M | $818K | $51K |
| Inventory | $5.2M | $5.27M | $3.7M | $985K | $387K | $75K | $0 | $0 | $0 |
| Other Current Assets | $925K | $1.03M | $1.86M | $925K | $4.45M | $0 | $0 | $0 | $591K |
| Total Current Assets | $68.36M | $109.58M | $76.36M | $112.01M | $156.48M | $128.64M | $10M | $19.59M | $11.94M |
| Long-Term Assets | |||||||||
| Property, Plant & Equipment Net | $5.97M | $9.22M | $8.91M | $6.28M | $5.85M | $5.46M | $1.74M | $383K | $412K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $55.96M | $56.29M | $52.07M | $44.66M | $28.29M | $21.67M | $7.19M | $0 | $0 |
| Long-Term Investments | $1.92M | $0 | $0 | $193K | $183K | $124K | $98K | $76K | $78K |
| Deferred Tax Assets | $97K | $85K | $63K | $53K | $51K | $44K | $26K | $32K | $25K |
| Other Long-Term Assets | $0 | $1.81M | $1.3M | $0 | $0 | $0 | $0 | $76K | $78K |
| Total Long-Term Assets | $63.94M | $67.39M | $62.35M | $51.18M | $34.38M | $27.3M | $9.06M | $492K | $515K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $132.31M | $176.97M | $138.71M | $163.19M | $190.85M | $155.94M | $19.06M | $20.09M | $12.45M |
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts Payable | $15.33M | $4.19M | $4.58M | $2.09M | $2.67M | $1.63M | $1.74M | $677K | $435K |
| Short-Term Debt | $26.54M | $277K | $407K | $435K | $619K | $1.49M | $900K | $323K | $441K |
| Current Income Tax Payable | $0 | $4.82M | $2.22M | $4.08M | $3.14M | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $998K | $131K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $7.4M | $2.64M | $1.21M | $694K | $1.28M | $4.6M | $2.07M | $353K | $287K |
| Total Current Liabilities | $54.68M | $24.05M | $16.14M | $16.66M | $12.93M | $8.75M | $5.49M | $2.23M | $1.95M |
| Long-Term Liabilities | |||||||||
| Long-Term Debt | $19.73M | $20.92M | $9.35M | $9.15M | $8.72M | $10.4M | $8.96M | $6.17M | $5.44M |
| Long-Term Unearned Revenue | $761K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $10K | $0 | $6K | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $1.56M | $2.61M | $217K | $66K | $103K | $51K | $724K | $0 | $0 |
| Total Long-Term Liabilities | $22.77M | $26.39M | $13.06M | $12.1M | $11.88M | $14.34M | $10.61M | $6.17M | $5.44M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $77.47M | $50.44M | $29.2M | $28.76M | $24.81M | $23.09M | $16.09M | $8.41M | $7.39M |
| Stockholders' Equity | |||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $7.26M | $7.18M | $5.5M | $4.96M | $4.95M | $5.19M | $3.11M | $2.77M | $2.24M |
| Retained Earnings | -$341.77M | -$243.25M | -$179.68M | -$132.07M | -$97.38M | -$82.48M | -$60.72M | -$44.48M | -$34.34M |
| Comprehensive Income & Other | $15.1M | $11.41M | $153K | $197K | $226K | $3.83M | $786K | $44K | $70K |
| Other Stockholders' Equity | $389.37M | $362.6M | $283.69M | $261.53M | $258.48M | $210.15M | $60.56M | $53.39M | $37.16M |
| Total Equity | $54.87M | $126.53M | $109.51M | $134.43M | $166.04M | $132.85M | $2.96M | $11.68M | $5.06M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $132.34M | $176.97M | $138.71M | $163.19M | $190.85M | $155.94M | $19.06M | $20.09M | $12.45M |
| Supplementary Data | |||||||||
| Total Debt | $46.99M | $25.31M | $14.19M | $13.27M | $13.04M | $15.77M | $10.78M | $6.5M | $5.88M |
| Net Debt | $13.49M | -$12.88M | -$9.95M | -$6.71M | -$138.35M | -$110.39M | $3.44M | -$12.28M | -$5.41M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Operating Activities | |||||||||
| Net Income | -$100.61M | -$63.05M | -$49.89M | -$33.58M | -$27.53M | -$13.58M | -$9.37M | -$10.1M | -$11.55M |
| Depreciation & Amortization | $5.01M | $3.04M | $2.64M | $2.16M | $1.86M | $693K | $484K | $106K | $97K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $0 | $4.43M | $2.92M | $3.01M | $1.42M | $2.85M | $387K | $31K | $27K |
| Changes in Working Capital: | |||||||||
| Accounts Receivable | -$2.39M | -$839K | -$1.72M | $8K | -$2.82M | $408K | -$1.55M | -$173K | -$180K |
| Inventory | $63K | -$1.57M | -$2.72M | -$599K | -$325K | -$61K | $0 | $0 | $0 |
| Accounts Payable | $8.33M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Working Capital | $0 | $5.71M | $535K | $687K | $1.87M | $1.24M | $2.62M | $398K | -$327K |
| Total Working Capital Change | $6M | $3.31M | -$3.9M | $96K | -$1.28M | $1.59M | $1.07M | $225K | -$507K |
| Other Non-Cash Items | $14.19M | -$2.73M | -$1.79M | -$3.82M | -$2.78M | $782K | $800K | $642K | $2.67M |
| Net Cash from Operating | -$75.41M | -$55M | -$50.03M | -$32.13M | -$28.31M | -$7.67M | -$6.63M | -$9.09M | -$9.26M |
| Investing Activities | |||||||||
| Capital Expenditures | -$4.21M | -$1.3M | -$2.79M | -$990K | -$1.64M | -$628K | -$57K | -$86K | -$102K |
| Acquisitions | $3K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$46.96M | -$109.3M | -$89.4M | -$114.65M | $0 | -$15K | -$11K | $0 | $0 |
| Sales of Investments | $80.4M | $95.31M | $134.82M | $32.3M | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | -$2.95M | -$6.87M | -$17.15M | -$11.56M | -$11.3M | -$6.41M | $2K | $0 |
| Net Cash from Investing | $29.24M | -$18.24M | $35.76M | -$100.49M | -$13.2M | -$11.95M | -$6.47M | -$84K | -$102K |
| Financing Activities | |||||||||
| Debt Repaid | -$23.67M | -$9.47M | $1.38M | $1.2M | $964K | -$663K | -$819K | - | -$1.24M |
| Common Stock Issuance | $23.3M | $77.89M | $20.49M | $285K | $86.84M | $115.72M | $0 | $16.76M | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$3.64M | -$847K | -$271K | -$187K | -$439K | -$169K | -$37K | $0 | $0 |
| Net Cash from Financing | $43.33M | $86.51M | $18.83M | -$1.1M | $85.43M | $116.22M | $782K | $16.76M | $1.24M |
| Forex Effect | $2.69M | $769K | -$412K | $2.31M | $4.35M | -$26K | $86K | -$98K | -$85K |
| Net Change in Cash | -$146K | $14.05M | $4.16M | -$131.41M | $48.27M | $96.58M | -$12.23M | $7.49M | -$8.2M |
| Supplementary Data | |||||||||
| Operating Cash Flow | -$75.41M | -$55M | -$50.03M | -$32.13M | -$28.31M | -$7.67M | -$6.63M | -$9.09M | -$9.26M |
| Capital Expenditure | -$899K | -$6.78M | -$12.25M | -$18.27M | -$13.2M | -$11.93M | -$6.46M | -$86K | -$102K |
| Free Cash Flow | -$76.31M | -$61.78M | -$62.27M | -$50.39M | -$41.51M | -$19.6M | -$13.09M | -$9.18M | -$9.36M |
| Cash at Beginning | $33.65M | $24.14M | $19.98M | $151.39M | $103.12M | $6.54M | $18.77M | $11.29M | $19.49M |
| Cash at End | $33.5M | $38.19M | $24.14M | $19.98M | $151.39M | $103.12M | $6.54M | $18.77M | $11.29M |